In SETD2 mutant ccRCC, LEDGF recognized H3R17me2a and activated the transcription of key enzymes in the nucleotide de novo synthesis pathway such as PPAT, promoting the proliferation of ccRCC. This evidence concerns the gene SETD2 and nonpapillary renal cell carcinoma.